Neurology

  1. Aimovig (erenumab-aooe)
    Aimovig (erenumab-aooe)
    by Amgen Inc., Novartis Pharmaceuticals Corporation
    for Migraine
    €896.00
  2. Austedo (deutetrabenazine)
    Austedo (deutetrabenazine)
    by Teva Pharmaceuticals
    for Huntington's Disease, Tardive Dyskenia
    €4,485.00
  3. Calcort (deflazacort)
    Calcort (deflazacort)
    by Merrell Dow/Henning
    for Duchenne Muscular Dystrophy
    €11.44
  4. Edaravone (generic)
    Edaravone (generic)
    by Daiichi Sankyo Company Limited
    for Cerebral Infarction
    €391.00
  5. Fycompa (perampanel)
    Fycompa (perampanel)
    by Eisai Europe Ltd
    for Epilepsy
    €15.80
  6. Mavenclad (cladribine)
    Mavenclad (cladribine)
    by Merck Serono Europe Limited
    for Multiple Sclerosis
    €2,612.80
  7. Nuplazid (pimavanserin)
    Nuplazid (pimavanserin)
    by ACADIA Pharmaceuticals Inc
    for Parkinson's Disease
    €5,539.55
  8. Ocrevus (ocrelizumab)
    Ocrevus (ocrelizumab)
    by Roche Registration Limited
    for Multiple Sclerosis
    €8,682.50
  9. Ongentys (opicapone)
    Ongentys (opicapone)
    by Bial - Portela & Ca, S.A.
    for Parkinson's Disease
    €221.95
View as Grid List

Items 1-9 of 12

Page
per page
Set Descending Direction

Just one thing before you continue

Our service contains information about acquiring treatments that have been approved in another country. This includes professional information such as approval details, product information and pricing. By scrolling, you are declaring that you are requesting any such information.

No, take me out of here.
CONTINUE